Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Agreements: Key Legal, Regulatory and IP Considerations for the EU and UK Markets (July 2, 2026)" training has been added to ResearchAndMarkets.com's offering.
The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector.
Having appropriate CTAs in place is therefore essential for managing relationships between the different stakeholders, and apportioning risk and responsibilities between them. If appropriate contractual arrangements are not in place, a clinical trial may not receive approval or issues may arise with the integrity or validity of the data collected. Further, disputes between the parties can arise if responsibilities are not clearly defined in the agreement.
This intensive training course provides essential insights into the legal framework governing clinical trials in the EU and UK, ensuring compliance, protecting intellectual property and managing liability risks.
The expert speakers will explain the dynamic and increasingly demanding regulatory and data protection landscape to better inform those negotiations and drafting these agreements.
Who Should Attend:
This training course has been specially designed for:
- Lawyers and in-house legal teams
- Contract managers
- Clinical contract specialists
- Clinical trial managers and professionals
- R&D staff
- Regulatory specialists
And CROs, sponsors and healthcare organisations looking to stay ahead in an evolving legal landscape.
Key Topics Covered:
- Overview of the regulation of clinical trials - the legal framework governing clinical trials in the EU and the UK
- Consent, data and IP rights
- Final questions
For more information about this training visit https://www.researchandmarkets.com/r/rdeng0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
